Abstract: In a communications system (1A), a communication service which is utilized by UE (10) is specified from among a first communication service and a second communication service, an address of a SGW (80) corresponding to a service type of the first communication service is retrieved when the specified communication service is the first communication service with reference to information in which the specified communication service and the address of the SGW (80) that transmits and receives data for utilizing the communication service are correlated with each other, and a SGW (80) other than a first communication control device is retrieved when the specified communication service is the second communication service.

Abstract: Disclosed are compounds of general formula A useful as potential anti-tubercular agents.

Abstract: A correspondence information storage 32 acquires correspondence information in which an eNB 20, an SGW-C 60, and an SGW-U 70 are associated with each other in advance, and a connection controller 31 receives a handover request from the eNB 20 and identifies a target eNB 20 and a source eNB 20. A connection changer 33 identifies the SGW-C 60 and the SGW-U 70 associated with the target eNB 20 and identifies the SGW-C 60 and the SGW-U 70 associated with the source eNB 20, with reference to the correspondence information. The connection changer 33 determines whether or not the SGW-C 60 and the SGW-U 70 are to be changed on the basis of the identified result, and controls change requests for at least one of the SGW-C 60 and the SGW-U 70 on the basis of a result of the determination.

Abstract: A control device for controlling an IP core network is disclosed. The device includes an interconnection gateway for connection with an external network and switches each connected to at least one access point. The device is configured to communicate with a control entity for controlling the switches and/or a control entity for controlling the gateway, to obtain communications parameters for a communications session of a communication terminal connected to an access point and comprising at least one parameter relating to a communications tunnel between a switch connected to the access point and the terminal. The device is configured to use said at least one communications parameter to produce at least one processing rule for processing data flows for the session, to be applied by the gateway, the switch, and/or the access point. The device is configured to transmit at least one rule to that piece of equipment.

Abstract: A control device can be used to control a base station, a switch, and a gateway leading to an external network. The device may communicate with a connection server connecting to a cloud computer system and with virtual functions of a control plane of the core network as instantiated in the computer system. The device may manage a database identifying for at least one terminal at least one of the virtual functions allocated to that terminal and a database associating at least one of the virtual functions with an identifier and a state of that function, and update the databases on the basis of information received from the connection server and/or from the virtual functions. The device may use one and/or the other of the databases in order to set up and/or maintain a user plane for a terminal between the base station, the switch, and the interconnection gateway.

Abstract: Disclosed are compounds of general formula A useful as potential anti-tubercular agents.

Abstract: The present disclosure provides compounds of general formula A: useful as potential anti-tubercular agents.

Abstract: The present invention provides a compound of general formulae A useful as potential anti-cancer agents against human cancer cell lines and a process for the preparation thereof.

Abstract: The present invention provides a compound of general formulae A useful as potential antitumor agents against human cancer cell lines and a process for the preparation thereof.

Abstract: The present invention provides a compound of general formulae A useful as potential antitumor agents against human cancer cell lines and a process for the preparation thereof.

Abstract: The present invention provides a compound of general formulae A useful as potential antitumour agents against human cancer cell lines. The present invention further provides a process for the preparation of pyrrolo[2, 1-c][1,4]benzodiazepine hybrids of general formulae 6a-g, 10a-o, 14a-g and 18a-o.

Abstract: The present invention provides a solid of pitavastatin tert-butyl ester and process for its preparation. The present invention also provides a novel crystalline form of pitavastatin calcium, process for its preparation and pharmaceutical compositions comprising it.

Abstract: The present invention provides compounds of general formula (3) as useful potential antitumour agents against human cancer cell lines. The present invention further provides a process for the synthesis of 4?-acrylamidopodophyllotoxin congeners of general formula (3), wherein R and R1 are an aryl group and R is selected from 3,4,5-trimethoxyphenyl or 2-methoxy phenyl and R1 is selected from the group consisting of 4-hydroxy-3-methoxyphenyl, 3-hydroxy-4-methoxyphenyl, 4-fluoro-3-methoxyphenyl, 3-fluoro-4-methoxyphenyl, 2-fluoro-5-methoxyphenyl, 2-fluoro-4-methoxyphenyl, 4-hydroxy-3-nitrophenyl, 4-methoxy-3-nitrophenyl, 4-nitrophenyl, 3-nitrophenyl, 2-nitro phenyl, 4-methoxyphenyl, 3-methoxyphenyl and 4-hydroxyphenyl.

Abstract: A compound of general formula 9, useful as potential antitumor agents against human cancer cell line and a process for the preparation of Pyrrolo[2,1-c] [1,4]benzodiazepine-benzothiazole or benzoxazole conjugates linked through piperazine of general formula 9 wherein: R, R1=H, F, OCF3, Cl, OMe; R2=OCH3 or H; n1 n2=3, 4; x=S or O.

Abstract: The present invention provides a compound of general formulae A useful as potential anti-cancer agents against human cancer cell lines and a process for the preparation thereof.

Abstract: The present invention provides a solid of pitavastatin tert-butyl ester and process for its preparation. The present invention also provides a novel crystalline form of pitavastatin calcium, process for its preparation and pharmaceutical compositions comprising it.

Abstract: The present invention provides compounds of general formula (3) as useful potential antitumour agents against human cancer cell lines. The present invention further provides a process for the synthesis of 4?-acrylamidopodophyllotoxin congeners of general formula (3), wherein R and R1 are an aryl group and R is selected from 3,4,5-trimethoxyphenyl or 2-methoxy phenyl and R1 is selected from the group consisting of 4-hydroxy-3-methoxyphenyl, 3-hydroxy-4-methoxyphenyl, 4-fluoro-3-methoxyphenyl, 3-fluoro-4-methoxyphenyl, 2-fluoro-5-methoxyphenyl, 2-fluoro-4-methoxyphenyl, 4-hydroxy-3-nitrophenyl, 4-methoxy-3-nitrophenyl, 4-nitrophenyl, 3-nitrophenyl, 2-nitro phenyl, 4-methoxyphenyl, 3-methoxyphenyl and 4-hydroxyphenyl.

Abstract: The present invention relates to chalcone linked pyrrolo[2,1-c][1,4]benzodiazepine hybrids and a process for the preparation there of. More particularly it relates to 7-Methoxy-8-{n[4-1-(2 or 4-substituted phenyl)-3-(4-hydroxy-3-methoxyphenyl)-2-propen-1-one]alkyl}-oxy}-(11aS)-1,2,3,11a-5H-pyrrolo[2,1-c][1,4]benzodiazepin-5-one and 7-Methoxy-8-{n-[-3-(4-hydroxy-3-methoxyphenyl)-1-(2,4-alkyl-3-quinolyl)-2-propen-1-one]alkyl}-oxy-(11aS)-1,2,3,11a-5H-pyrrolo[2,1-c][1,4]benzodiazepin-5-one with aliphatic chain length variations useful as anticancer (antitumor) agent. The general structural formula of these chalcone linked pyrrolo[2,1-c][1,4]benzodiazepines hybrids is given below. wherein R1=OH, methyl, ethyl or phenyl; R2=H, OH or F; R=H or methyl; x=c or N; n=1-4.

Abstract: The present invention provides a compound of general formulae A useful as potential antitumour agents against human cancer cell lines. The present invention further provides a process for the preparation of pyrrolo[2,1-c][1,4]benzodiazepine hybrids of general formulae 6a-g, 10a-o, 14a-g and 18a-o.

Abstract: A compound of general formula 9, useful as potential antitumour agents against human cancer cell line and a process for the preparation of Pyrrolo[2,1-c] [1,4]benzodiazepine-benzothiazole or benzoxazole conjugates linked through piperazine of general formula 9 wherein: R, R1=H, F, OCF3, Cl, OMe; R2=OCH3 or H; n1 n2=3, 4; x=S or O.